The aim of this ESC Guideline is to help health professionals manage people with heart
failure (HF) according to the best available evidence. Fortunately, we now have a wealth of …

Wearable Digital Health Technologies for Monitoring in Cardiovascular Medicine | New England
Journal of Medicine Skip to main content The New England Journal of Medicine homepage …

Background Previous studies have suggested that haemodynamic-guided management
using an implantable pulmonary artery pressure monitor reduces heart failure …

Background The effect of haemodynamic monitoring of pulmonary artery pressure has
predominantly been studied in the USA. There is a clear need for randomised trial data from …

Self‐care is essential in the long‐term management of chronic heart failure. Heart failure
guidelines stress the importance of patient education on treatment adherence, lifestyle …

5.2. 1. Ocena funkcji skurczowej lewej komory...................................... 1052 5.2. 2. Ocena
funkcji rozkurczowej lewej komory...................................... 1052 5.2. 3. Ocena funkcji prawej …

Background Heart failure is a major and growing medical and economic problem worldwide
as 1–2% of the healthcare budget are spent for heart failure. The prevalence of heart failure …

Pulmonary hypertension (PH) is a pathophysiological disorder that may involve multiple
clinical conditions and may be associated with a variety of cardiovascular and respiratory …

Heart failure (HF) with preserved ejection fraction (EF; HFpEF) accounts for 50% of HF
cases, and its prevalence relative to HF with reduced EF continues to rise. In contrast to HF …

Background: Ambulatory hemodynamic monitoring with an implantable pulmonary artery
(PA) sensor is approved for patients with New York Heart Association Class III heart failure …